Methicillin-resistant Staphylococcus aureus disease in three communities.

By S. Fridkin, J. Hageman, M. Morrison, L. T. Sanza, K. Como‐Sabetti, J. Jernigan, K. Harriman, L. Harrison, R. Lynfield, M. Farley. New England Journal of Medicine, 2005

1,554 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/2f6e7baedac9613211228b0d2d79b09fa6f87954

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

1. Victor J. Torres
2. F. Tenover
3. Ramanan Laxminarayan
4. Eili Y. Klein
5. David L. Smith
6. D. Levine
7. Robert S. Daum
8. S. Cosgrove

In Epidemiology

1. Ramanan Laxminarayan
2. Eili Y. Klein
3. David L. Smith
4. F. Tenover
5. Robert S. Daum
6. H. Boucher
7. G. Corey
8. David J. Payne

In Infectious Diseases

1. Victor J. Torres
2. Robert S. Daum
3. Ashley L. DuMont
4. F. Tenover
5. Ramanan Laxminarayan
6. Eili Y. Klein
7. David L. Smith
8. Bo Shopsin

Citations in the corpus

• Invasive methicillin-resistant Staphylococcus aureus infections in the United States. (2007, methodology): “During surveillance conducted in 2000-2001, patient interviews were used to elicit undocumented health care risk factors; however, the effect on reclassification was small.(13) Third, our surveillance sites were largely urban areas; thus, we might be overestimating the incidence of invasive MRSA.”
• Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. (2006, background): “A critical question is whether more-virulent strains are more likely to cause disease than are less-virulent strains of those that colonize persons [35].”
• Staphylococcus aureus targets the Duffy antigen receptor for chemokines (DARC) to lyse erythrocytes (2015, background): “The current epidemic of CA-MRSA in the United States and elsewhere disproportionally affects individuals of African descent with severe and invasive infections (Fridkin et al., 2005).”
• The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. (2008, neutral): “global pandemic of methicillin-resistant Staphylococcus aureus (MRSA) infection [5-12]; the global spread of”
• Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults (2007, neutral): “2% of CA-MRSA infections were pneumonia [203].”
• Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005 (2007, positive): “Regardless, our fi ndings demonstrate that recent reports of localized increases in community-acquired MRSA ( 7 , 26 – 28 ) are part of a larger trend of MRSA becoming rapidly endemic in communities all over the United states, emulating the wave-like pattern of emerging resistance to penicillin in…”
• Epidemiology of methicillin-resistant Staphylococcus aureus. (2008, background): “Although there are no established risk factors for community-associated MRSA infection [42], person-to-person transmission has been reported [46], and several factors have been shown to predict disease (table 2).”
• Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis (2010, background): “Furthermore, we demonstrate that the lukAB promoter is activated in vivo and that LukAB is required for the full pathogenesis of the CA-MRSA strain LAC in a murine model of infection.”
• Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. (2008, neutral): “community [3, 4].”